Davorka Tomic Selected Research

Bradycardia

2/2014

Assessment of cardiac safety during fingolimod treatment initiation in a real-world relapsing multiple sclerosis population: a phase 3b, open-label study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Davorka Tomic Research Topics

Disease

23	Multiple Sclerosis 03/2024 - 02/2014
9	Relapsing-Remitting Multiple Sclerosis 12/2021 - 11/2014
3	Inflammation (Inflammations) 03/2024 - 01/2016
3	Chronic Progressive Multiple Sclerosis 01/2022 - 01/2021
2	Rheumatoid Arthritis 08/2023 - 01/2023
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 08/2023 - 01/2023
2	Disease Progression 01/2022 - 11/2014
2	Atrophy 01/2022 - 06/2016
1	Infections 01/2023
1	Progressive Multifocal Leukoencephalopathy 02/2022
1	Acute Disease 01/2022
1	Ganglion Cysts (Ganglion) 01/2020
1	Optic Neuritis (Retrobulbar Neuritis) 01/2020
1	Bradycardia 02/2014
1	Parkinson Disease (Parkinson's Disease) 03/2010

Drug/Important Bio-Agent (IBA)

16	Fingolimod Hydrochloride (FTY720)FDA Link 02/2022 - 02/2014
5	evobrutinibIBA 03/2024 - 01/2023
4	siponimodIBA 01/2022 - 02/2017
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2019
4	GadoliniumIBA 01/2022 - 11/2014
3	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024 - 01/2023
3	InterferonsIBA 01/2020 - 05/2016
2	Natalizumab (Tysabri)FDA Link 02/2022 - 07/2015
2	teriflunomideIBA 01/2020 - 11/2014
1	COVID-19 VaccinesIBA 10/2023
1	ofatumumab FDA Link 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Dimethyl FumarateIBA 11/2014
1	Adenosine A2 Receptor AntagonistsIBA 03/2010

Therapy/Procedure

8	Therapeutics 02/2022 - 11/2014
1	Injections 01/2020